Article metrics
PDF
Other content recommended for you
- Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers
- Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015
- Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision
- Understanding the language barriers to translating informed consent documents for maternal health trials in Zambia: a qualitative study
- Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
- Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants’ experiences and lessons learnt
- Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
- Engaging African ancestry participants in SLE clinical trials
- Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland
- Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study